Effects of opioid therapy on human natural killer cells

International Immunopharmacology

Volumn 18, Issue 1, 2014, Pages 169-174

  Tabellini, Giovanna ^a   Borsani, Elisa ^a   Benassi, Marzia ^a   Patrizi, Ornella ^a   Ricotta, Doris ^a   Caimi, Luigi ^a   Lanzi, Roberto ^a   Micheli, Fabrizio ^b   Iorno, Vittorio ^c   Bettaglio, Raffaella ^d   Rezzani, Rita ^a   Rodella, Luigi F ^a   Parolini, Silvia ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d IRCCS   (Italy)

Author keywords

Chronic pain; Human subjects; NK cells; Opioid therapy

Indexed keywords

BUPRENORPHINE; CD56 ANTIGEN; MORPHINE; OPIATE; OXYCODONE;

ADULT; AGED; ARTICLE; CELL FUNCTION; CELL SUBPOPULATION; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOMETRY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; NEUROPATHIC PAIN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHRONIC PAIN; HUMAN SUBJECTS; NK CELLS; OPIOID THERAPY;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANTIGENS, CD56; CELLS, CULTURED; CHRONIC PAIN; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MORPHINE; RECEPTORS, KIR; YOUNG ADULT;

EID: 84889569874     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.11.015     Document Type: Article

References (35)

1. Y. Shavit, A. Depaulis, F.C. Martin, G.W. Terman, R.N. Pechnick, and C.J. Zane Involvement of brain opiate receptors in the immune-suppressive effect of morphine Proc Natl Acad Sci U S A 83 1986 7114 7117 (Pubitemid 17172840)
2. B.M. Bayer, S. Daussin, M. Hernandez, and L. Irvin Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism Neuropharmacology 29 1990 369 374 (Pubitemid 20113897)
3. H.U. Bryant, E.W. Bernton, and J.W. Holaday Immunomodulatory effects of chronic morphine treatment: pharmacologic and mechanistic studies NIDA Res Monogr 96 1990 131 149
4. L.L. Lockwood, L.H. Silbert, M. Fleshner, M.L. Laudenslager, L.R. Watkins, and S.F. Maier Morphine-induced decreases in in vivo antibody responses Brain Behav Immun 8 1994 24 36 (Pubitemid 24163518)
5. C.Y. Hung, S.S. Lefkowitz, and W.F. Geber Interferon inhibition by narcotic analgesics Proc Soc Exp Biol Med 142 1973 106 111
6. J.M. Risdahl, K.V. Khanna, P.K. Peterson, and T.W. Molitor Opiates and infection J Neuroimmunol 83 1998 4 18 (Pubitemid 28280946)
7. M.P. Yeager, and T.A. Colacchio Effect of morphine on growth of metastatic colon cancer in vivo Arch Surg 126 1991 454 456
8. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189 220 (Pubitemid 29241123)
9. L.L. Lanier NK cell recognition Annu Rev Immunol 23 2005 225 274 (Pubitemid 40563170)
10. A. Moretta, E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta NK cells at the interface between innate and adaptive immunity Cell Death Differ 15 2008 226 233
11. E.O. Long Negative signaling by inhibitory receptors: the NK cell paradigm Immunol Rev 224 2008 70 84
12. M.A. Cooper, T.A. Fehniger, and M.A. Caligiuri The biology of human natural killer-cell subsets Trends Immunol 22 2001 633 640 (Pubitemid 33043908)
13. D. Mavilio, G. Lombardo, J. Benjamin, D. Kim, D. Follman, and E. Marcenaro Characterization of CD56 -/CD16 + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals Proc Natl Acad Sci U S A 102 2005 2886 2891 (Pubitemid 40299886)
14. M.A. Caligiuri Human natural killer cells Blood 112 2008 461 469
15. S. Parolini, C. Bottino, M. Falco, R. Augugliaro, S. Giliani, and R. Franceschini X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells J Exp Med 192 2000 337 346 (Pubitemid 30629159)
16. R. Pacifici, G. Patrini, I. Venier, D. Parolaro, P. Zuccaro, and E. Gori Effect of morphine and methadone acute treatment on immunological activity in mice: pharmacokinetic and pharmacodynamic correlates J Pharmacol Exp Ther 269 1994 1112 1116 (Pubitemid 24204193)
17. P. Sacerdote, M. Bianchi, L. Gaspani, B. Manfredi, A. Maucione, and G. Terno The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients Anesth Analg 90 2000 1411 1414 (Pubitemid 30351347)
18. P. Sacerdote, B. Manfredi, P. Mantegazza, and A.E. Panerai Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study Br J Pharmacol 121 1997 834 840 (Pubitemid 27260792)
19. A. Borman, Z. Ciepielewski, D. Wrona, W. Stojek, W. Glac, and E. Leszkowicz Small doses of morphine can enhance NK cell cytotoxicity in pigs Int Immunopharmacol 9 2009 277 283
20. A. Lopker, L.G. Abood, W. Hoss, and F.J. Lionetti Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes Biochem Pharmacol 29 1980 1361 1365 (Pubitemid 10149313)
21. R.J. McDonough, J.J. Madden, A. Falek, D.A. Shafer, M. Pline, and D. Gordon Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes J Immunol 125 1980 2539 2543 (Pubitemid 11204150)
22. H.U. Bryant, E.W. Bernton, and J.W. Holaday Immunosuppressive effects of chronic morphine treatment in mice Life Sci 41 1987 1731 1738
23. R.J. Weber, R. Gomez-Flores, J.E. Smith, and T.J. Martin Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse J Neuroimmunol 147 2004 134 137 (Pubitemid 38114964)
24. Y. Shavit, F.C. Martin, R. Yirmiya, S. Ben-Eliyahu, G.W. Terman, and H. Weiner Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity Brain Behav Immun 1 1987 318 328
25. R.J. Weber, B. Ikejiri, K.C. Rice, A. Pert, and A.A. Hagan Opiate receptor mediated regulation of the immune response in vivo NIDA Res Monogr 76 1987 341 348
26. D.T. Lysle, M.E. Coussons, V.J. Watts, E.H. Bennett, and L.A. Dykstra Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone J Pharmacol Exp Ther 265 1993 1071 1078 (Pubitemid 23321003)
27. L.R. Flores, S.M. Wahl, and B.M. Bayer Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking J Pharmacol Exp Ther 272 1995 1246 1251
28. Y. Shavit, J.W. Lewis, G.W. Terman, R.P. Gale, and J.C. Liebeskind Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity Science 223 1984 188 190 (Pubitemid 14212071)
29. D.J. Carr, L.R. Gerak, and C.P. France Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice J Pharmacol Exp Ther 269 1994 693 698 (Pubitemid 24157339)
30. R. Gomez-Flores, and R.J. Weber Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray Immunopharmacology 48 2000 145 156 (Pubitemid 30608671)
31. L. Gaspani, M. Bianchi, E. Limiroli, A.E. Panerai, and P. Sacerdote The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats J Neuroimmunol 129 2002 18 24 (Pubitemid 34874905)
32. T. Yokota, K. Uehara, and Y. Nomoto Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity J Anesth 18 2004 190 195 (Pubitemid 39264211)
33. B. Welden, G. Gates, R. Mallari, and N. Garrett Effects of anesthetics and analgesics on natural killer cell activity AANA J 77 2009 287 292
34. R. Jacobs, M. Karst, D. Scheinichen, C. Bevilacqua, U. Schneider, and J. Heine Effects of fentanyl on cellular immune functions in man Int J Immunopharmacol 21 1999 445 454 (Pubitemid 29306926)
35. M.P. Yeager, M.A. Procopio, J.A. DeLeo, J.L. Arruda, L. Hildebrandt, and A.L. Howell Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans Anesth Analg 94 2002 94 99 [table of contents] (Pubitemid 34038726)